Bio Path | BPTH - Ebit

Aktienkurs
0.06
Täglich Wechseln
-0.01 -12.31%
Monatlich
-5.00%
Jährlich
-66.47%
Q1 Prognose
0.06




Ebit Veränderung Datum
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
Baxter International USD -214.2M 415.4M 2025-12
Bio Path USD -488K 4.07M 2025-09
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD 56.04M 63.94M 2025-12
CSL USD 2.64B 116M 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09